CSS »

Revance Therapeutics shares owned by CSS

Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by CSS from 13F filings

Historical chart of CSS investment in Revance Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Revance Therapeutics held by CSS consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Revance Therapeutics by CSS

Quarter filed Position value Share count Share price at filing
2024-09-30 $547k 105k 5.19

More positions owned by CSS

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Carnival Corp Unit 99/99/9999 (CCL)
Axon Enterprise Note 0.500%12/1 (Principal)
Microstrategy Cl A New (MSTR)
American Airlines Group Note 6.500% 7/0 (Principal)
Macom Tech Solutions Hldgs I Note 0.250% 3/1 (Principal)
Stride Note 1.125% 9/0 (Principal)
Peabody Engr Corp Note 3.250% 3/0 (Principal)
Insmed Note 0.750% 6/0 (Principal)
Rbc Bearings 5% Cnv Pfd Sr A (RBCP)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
American Airls (AAL)
Ionis Pharmaceuticals Note 4/0 (Principal)
Datadog Note 0.125% 6/1 (Principal)
Marriott Vacations Worldwide Note 1/1 (Principal)

View all positions for CSS

Top funds holding Revance Therapeutics

BlackRock
BlackRock
Vanguard Group
Franklin Resources
Alpine Associates Management
Magnetar Financial
Tang Capital Management
Geode Capital Management
State Street Corporation
LMR Partners
D. E. Shaw & Co
Omni Event Management
Palo Alto Investors
CNH Partners
Gabelli Funds

View all funds holding Revance Therapeutics